Populative research conducted by Danish scientists revealed the connection between the reception of hormonal contraceptives and an increased risk of gyoma development among girls.
Content
According to the report published in the British magazine
Clinical pharmacology, long-term use of hormonal contraceptives
Increases the risk of brain glioma almost twice.
It has long been known that consumption of hormonal
Contraceptives can contribute to the development of certain types of cancer,
However, the relationship between their reception and development of TSNS tumors was not investigated enough.
During the study, David Geyst (doctor of medicine, hospital doctor
Oden University and University of South Denmark) with colleagues appealed to
Medical maps of patients-sensing ages aged 15 to 49 years old, in which
The period from 2000 to 2009 was diagnosed by Gliom. In addition, were studied
Archives of medical recipes for hormonal drugs, discharged in the period from
1995 to 2009.
317 women with
diagnosed glioma and 2,126 women of the control group — about
one age, with an equal number of birth in history and the same level
Education.
It was found that women who took hormonal
Contraceptive drugs at the time of study or shortly before it, risk
Glioma development is higher than women who took them in the past. The group is increased
Risks were attributed to women who take purely progestic drugs (mini-drank),
However, women taking estrogen-progestin contraceptives were also attributed
To the risk group on the development of brain glioma.
Dr. Brittani Charmlton (Doctor of Science, Researcher with
scientist degree in the Boston Children's Hospital and Harvard Medical School)
I am sure that it is confident that to properly assess all risks associated with the application
Hormonal contraceptives, should collect detailed information about patients
and observe them for a long period, because over time medical
Preparations change. So, in modern drugs changed content
Estrogen, proced progesterone in them, changed the schemes of reception, steel
Hormonal intrauterine contraceptives apply.
Dr. Caetelin Igan from the oncological center in Tampa (staff
Florida) believes that the pluses of research include the coverage of the large part
population and obtaining information on the use of oral contraceptives from
medical maps, and not from patients. To minuses — that in it
There were relatively few women with diagnosed glioma; What authors
Studies did not have access to such meaningful information as the mass index
Body, so the results of the study require further confirmation.
The most famous complications when receiving hormonal
Contraceptives of combined action — venous and arterial thrombosis and
Certain types of cancer, including breast cancer and cervical cancer. However
This use of these drugs contributes to a decrease in the risk of ovarian cancer,
Endometrial cancer and colon cancer. In addition, KOK is used for
treatment of heavy menstrual bleeding, dysmenorrhea, hirsutism and
adolescent eels. In general, the use of hormonal contraceptives increases
The average duration of life. Head of Research Dr. David Gaist
argues that the benefits of using hormonal contraceptives are essential
Out of revealed risks.